Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEA-LUT for Post-COVID Olfactory Dysfunction
NCT04853836Phase 4Completed
- Sponsor
- University of Perugia
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of palmitoylethanolamide + luteolin in Olfactory dysfunction, sponsored by University of Perugia. Primary endpoint: Recovery of smell at 90 days. Started Nov 2020; status: completed.
02
Drugs
palmitoylethanolamide + luteolin
03
Conditions
Olfactory dysfunction
Beyond the preview
Go deeper on NCT04853836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04853836.